Document is current
Any future updates will be listed below
-
Authors
Capone, Mariaelena
Fratangelo, Federica
Giannarelli, Diana
Sorrentino, Claudia
Turiello, Roberta
Zanotta, Serena
Galati, Domenico
Madonna, Gabriele
Tuffanelli, Marilena
Scarpato, Luigi
Grimaldi, Antonio M.
Esposito, Assunta
Azzaro, Rosa
Pinto, Antonio
Cavalcanti, Ernesta
Pinto, Aldo
Morello, Silvana
Ascierto, Paolo A.
- License Information
-
More Information
Article History
Received: 23 October 2019
Accepted: 27 February 2020
First Online: 11 March 2020
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale”, Naples, Italy. A signed informed consent from patients was obtained for blood donation.
: Not applicable.
: PA. Ascierto has/had a consultant/advisory role for Bristol Myers-Squibb, Roche-Genentech, Merck Sharp & Dohme, Array, Novartis, Merck Serono, Pierre Fabre, Incyte, NewLink Genetics, Genmab, Medimmune, AstraZeneca, Syndax, Sanofi, Idera, SunPharma, Ultimovacs, Sandoz, Immunocore, 4SC. He also received Research funds from Bristol Myers-Squibb, Roche-Genentech, Array, and travel support from MSD.Antonio M. Grimaldi received honoraria from Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Merk Serono and Roche Genentech, and had consultant/advisory role for Bristol-Myers Squibb, Merck Sharp & Dohme and Novartis.Antonio Pinto received honoraria from Roche, Bristol-Myers Squibb, Celgene, Servier, MDS, had consultant/advisory role for Servier, Roche, Brystol-Myers Squibb, MDS, Novartis. He received travel support from Roche and Takeda.The other authors declare no potential competing interests.
